Papers

TO
ABSTRACT

Business Models to Cure Rare Disease: A Case Study of Solid Biosciences

Healthcare Finance 2016 Kim, Esther S. and Andrew W. Lo, Journal of Investment Management 14, 87-101.
ABSTRACT

A Simple Hedge for Longevity Risk and Reimbursement Risk Using Research-Backed Obligations (Working Paper)

Healthcare Finance 2016 Stein, Roger M. MIT Sloan School Working Paper 5165-16.
ABSTRACT

Buying Cures Versus Renting Health: Financing Health Care with Consumer Loans

Healthcare Finance 2016 Vahid Montazerhodjat, David M. Weinstock, Andrew W. Lo, Science Translational Medicine,, Vol. 8, Issue 327, pp. 327ps6
ABSTRACT

Financing Drug Discovery via Dynamic Leverage

Healthcare Finance 2015 Montazerhodjat, Vahid, John J. Frishkopf, and Andrew W. Lo, Drug Discovery Today 21, 410-414.
ABSTRACT

Lessons from Hollywood: A New Approach to Funding R&D

Healthcare Finance 2015 Lo, Andrew W. and Gary P. Pisano, MIT Sloan Management Review 57(2).
ABSTRACT

Funding Translational Medicine via Public Markets: The Business Development Company

Healthcare Finance 2015 Forman, Sandra M., Andrew W. Lo, Monica Shilling, and Grace Sweeney, Journal of Investment Management 13 (4), 9-32.
ABSTRACT

Viewpoint: Health, Wealth, and 21st Century Cures

Healthcare Finance 2015 Lo, Andrew W., Tomas J. Philipson, and Andrew C. von Eschenbach, JAMA Oncology, published online October 29. doi:10.1001/jamaoncol.2015.4221.
ABSTRACT

FAQs for Megafund Financing

Healthcare Finance 2015 Fernandez, Jose-Maria, Roger M. Stein, and Andrew W. Lo
ABSTRACT

Is the FDA Too Conservative or Too Aggressive?: A Bayesian Decision Analysis of Clinical Trial Design (Working Paper)

Healthcare Finance 2015 Montazerhodjat, Vahid and Andrew W. Lo
ABSTRACT

Financing Translation: Analysis of the NCATS Rare-Diseases Portfolio

Healthcare Finance 2015 Fagnan, David E., N. Nora Yang, John C. McKew, and Andrew W. Lo, Science Translational Medicine 7(276), 276ps3.